NCT00046423View on ClinicalTrials.gov

A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2000

Conditions
NeoplasmsMetastases, Neoplasm
Interventions
DRUG

ABI-007

Trial Locations (1)

27703

Abraxis Bioscience, Inc., Durham

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY